Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Intuit cuts 17% of global workforceUS doctor in contact with Ebola patient heading to Czech hospitalWendy's names Robert Wright as new CEOStellantis, JLR to Explore Joint US Vehicle DevelopmentAzerbaijan pavilion captivates tourists at WUF13Gas to be cut in Gabala and Zagatala139 Ebola Deaths: WHO Sounds AlarmDeputy Minister: Principle is to reduce risks before disasterDmitri Mariyasin: Earthquakes Reveal Urban Structural WeaknessesTSX futures rise on inflation worries, Nvidia earningsIntuit cuts 17% of global workforceUS doctor in contact with Ebola patient heading to Czech hospitalWendy's names Robert Wright as new CEOStellantis, JLR to Explore Joint US Vehicle DevelopmentAzerbaijan pavilion captivates tourists at WUF13Gas to be cut in Gabala and Zagatala139 Ebola Deaths: WHO Sounds AlarmDeputy Minister: Principle is to reduce risks before disasterDmitri Mariyasin: Earthquakes Reveal Urban Structural WeaknessesTSX futures rise on inflation worries, Nvidia earnings
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU
COMPANY

Savara Presents Molgramostim Biomarker Data at ATS

Savara presented molgramostim biomarker data from IMPALA-2 Phase 3 trial at ATS 2026. Key results show improved lung function and biomarker reductions.

Benjamin Moore
ByBenjamin Moore- Senior Editor
|
0
Savara Presents Molgramostim Biomarker Data at ATS
Photo: Prepared by Bond.az

Savara Inc. (NASDAQ:SVRA) presented biomarker data from its IMPALA-2 Phase 3 trial at the ATS 2026 International Conference.

The double-blind, placebo-controlled study included 81 patients on molgramostim and 83 on placebo.

Molgramostim showed significant improvements in pulmonary gas transfer and reductions in biomarkers LDH, CYFRA 21-1, and KL-6.

According to Bond.az, Savara has a market cap of $1.2 billion and holds more cash than debt.

More News
McKinsey partner joins Verisk board
Today / 12:54
|
798

McKinsey partner joins Verisk board

Verisk appoints McKinsey senior partner Pradip Patiath to its board. Stock down 45% but company shows strong fundamentals with 70% gross margins.

COMPANY →
0
LZ Technology executes 1-for-20 reverse stock split
Today / 12:53
|
974

LZ Technology executes 1-for-20 reverse stock split

LZ Technology executes 1-for-20 reverse stock split to boost share price and maintain NASDAQ listing.

COMPANY →
0
Tether acquires SoftBank's stake in Twenty One Capital
Today / 12:30
|
834

Tether acquires SoftBank's stake in Twenty One Capital

Tether International acquires SoftBank Group's stake in Bitcoin company Twenty One Capital. Control shift in the Bitcoin-focused firm.

COMPANY →
0
EuroDry Q1 net income $0.3M, orders two ships
Today / 12:14
|
776

EuroDry Q1 net income $0.3M, orders two ships

EuroDry reports Q1 2026 net income of $0.3 million and orders two Kamsarmax vessels for 2028 delivery.

COMPANY →
0
Capital Limited shareholders approve all AGM resolutions
Today / 11:20
|
931

Capital Limited shareholders approve all AGM resolutions

Capital Limited shareholders approved all resolutions at the AGM. Voting results and company performance details.

COMPANY →
0
AEP Plantations Monitors Indonesia CPO Export Proposal
Today / 10:54
|
247

AEP Plantations Monitors Indonesia CPO Export Proposal

AEP Plantations monitors Indonesia's CPO export proposal. No direct impact expected, but indirect pricing effects possible.

COMPANY →
0
M&S Non-Executive Director Steps Down
Today / 09:41
|
733

M&S Non-Executive Director Steps Down

Marks & Spencer Non-Executive Director Cheryl Potter to step down on July 7, 2026. Bond.az reports.

COMPANY →
0
DiaSorin Sees 2026 Revenue Growth of 5%-6%
Today / 09:33
|
238

DiaSorin Sees 2026 Revenue Growth of 5%-6%

DiaSorin projects 2026 revenue growth of 5%-6%. Shares dip 1% in Milan. Read more on Bond.az.

COMPANY →
0
Maven admits 238,026 new shares
Today / 09:33
|
215

Maven admits 238,026 new shares

Maven Income and Growth VCT 5 admits 238,026 new shares on LSE under Dividend Investment Scheme. Total shares now 264,875,572.

COMPANY →
0
Maven VCT 4 admits 176,625 new shares
Today / 09:20
|
399

Maven VCT 4 admits 176,625 new shares

Maven Income & Growth VCT 4 announces admission of 176,625 new shares to trading on London Stock Exchange.

COMPANY →
0
Energean pulls three AGM resolutions
Today / 07:12
|
544

Energean pulls three AGM resolutions

Energean withdraws three resolutions from AGM agenda. The resolutions related to pre-emption rights and meeting notice periods.

COMPANY →
0
Stellantis and Dongfeng plan Europe joint venture for EVs
Today / 07:10
|
718

Stellantis and Dongfeng plan Europe joint venture for EVs

Stellantis and Dongfeng plan a Europe-based joint venture for electric vehicles. Stellantis will hold 51%, Dongfeng 49%.

COMPANY →
0
...
Savara Presents Molgramostim Biomarker Data at ATS | Bond.az